The Global Dysmenorrhea Treatment Industry, a crucial player in women’s health, has demonstrated robust growth, reaching a valuation of US$ 5,937.8 million by the end of 2022. As we usher in 2023, the market is poised to experience even greater demand, with an estimated value of US$ 6,324.5 million, reflecting an impressive year-on-year growth rate …